News

Eli Lilly gets a boost from new pill data; execs say US fast track not a sure thing

Eli Lilly's bid for approval for an experimental weight-loss pill got a boost on Wednesday with new clinical trial data, but ...

Eli Lilly and Company (LLY) Diabetes Medication Successful in Children and Adolescents

Eli Lilly and Co. (NYSE: LLY) is one of the best beginner stocks to buy, according to analysts. On September 17, the company ...
STAT

Pharmalittle: We’re reading about dueling data from Lilly and Novo, a Roche deal, and much more

Novo Nordisk's diabetes blockbuster Ozempic beat Eli Lilly’s older drug Trulicity in a real-world study of certain U.S. patients ...

Eli Lilly cautious on using FDA fast-track voucher for weight-loss pill

Eli Lilly's international president said on Wednesday it was too early to assume the company would use the U.S. Food and Drug ...

Mounjaro sales help almost double Ely Lilly’s UK turnover

The sale of weight loss drug Mounjaro has boosted the UK turnover of pharmaceuticals giant Eli Lilly by 90 per cent during ...
BioSpace

FDA’s Ad Crackdown Targets Novo, Lilly’s Oprah Special on GLP-1s

In letters to Eli Lilly and Novo Nordisk, the FDA accused the companies of downplaying the risks of their GLP-1 weight loss ...

Lilly sees obesity drug leadership beyond US as it leans on consumer-focused strategy

Eli Lilly has established itself as the market leader in obesity drugs in Europe, Asia and the Middle East and expects to ...